WO03/062224 is an in vivo selective agonist at nicotinic β4 receptors

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 1, 2008, Pages 9-13

  Greenhalgh, Clare E ^a   Smith, Janice W ^b   Clifton, Peter G ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Beta 4 agonist; Instrumental responding; Locomotor activity; Rat; Selective nicotinic

Indexed keywords

1 METHYL 4 (2 CHLORO 4 HYDROXYPHENYLTHIO)PIPERIDINE; NICOTINIC AGENT; NICOTINIC BETA4 RECEPTOR; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; WO 03 062224;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DRUG SELECTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CONDITIONING, OPERANT; DATA INTERPRETATION, STATISTICAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NICOTINIC AGONISTS; PIPERIDINES; RECEPTORS, NICOTINIC; REINFORCEMENT SCHEDULE;

ANIMALIA; MUS; RATTUS;

EID: 50349090047     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.06.005     Document Type: Article

References (37)

1. Azam L., Winzer-Serhan U.H., Chen Y., and Leslie F.M. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol 444 (2002) 260-274
2. Bartus R.T., Dean R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-414
3. Bencherif M., Bane A.J., Miller C.H., Dull G.M., and Gatto G.J. TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors. Eur J Pharmacol 409 (2000) 45-55
4. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 64 (1995) 749-760
5. Bontempi B., Whelan K.T., Risbrough V.B., Rao T.S., Buccafusco J.J., Lloyd G.K., et al. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates. J Pharmacol Exp Ther 299 (2001) 297-306
6. Clarke P.B., and Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78 (1983) 329-337
7. Colquhoun L.M., and Patrick J.W. Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv Pharmacol 39 (1997) 191-220
8. Cooper E., Couturier S., and Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350 (1991) 235-238
9. Corringer P.J., Le Novere N., and Changeux J.P. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40 (2000) 431-458
10. Dalton G.L., Lee M.D., Kennett G.A., Dourish C.T., and Clifton P.G. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology 46 (2004) 663-671
11. Dineley-Miller K., and Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Mol Brain Res 16 (1992) 339-344
12. Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., and Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79 (1994) 705-715
13. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annu Rev Psychol 48 (1997) 649-684
14. Farlow M. A clinical overview of cholinesterase inhibitors in Alzheimer's disease. Int Psychogeriatr 14 (2002) 93-126
15. Fu Y., Matta S.G., McIntosh J.M., and Sharp B.M. Inhibition of nicotine-induced hippocampal norepinephrine release in rats by alpha-conotoxins MII and AuIB microinjected into the locus coeruleus. Neurosci Lett 266 (1999) 113-116
16. Gahring L.C., Persiyanov K., and Rogers S.W. Neuronal and astrocyte expression of nicotinic receptor subunit beta4 in the adult mouse brain. J Comp Neurol 468 (2004) 322-333
17. Gotti C., Fornasari D., and Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol 53 (1997) 199-237
18. Graham A.J., Martin-Ruiz C.M., Teaktong T., Ray M.A., and Court J.A. Human brain nicotinic receptors, their distribution and participation in neuropsychiatric disorders. Curr Drug Targets CNS Neurol Disord 1 (2002) 387-397
19. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., and Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383 (1996) 713-716
20. Greenhalgh C.E., and Clifton P.G. Effects of nicotinic receptor agonists on locomotor activity and appetitive and consummatory components of feeding. Behav Pharmacol 16 (2005) S67-S67
21. Grottick A.J., Wyler R., and Higgins G.A. A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task. Pharmacol Biochem Behav 70 (2001) 505-513
22. King S.L., Caldarone B.J., and Picciotto M.R. Beta2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration. Neuropharmacology 47 Suppl 1 (2004) 132-139
23. Le Novere N., Corringer P.J., and Changeux J.P. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53 (2002) 447-456
24. Levin E.D., and Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138 (1998) 217-230
25. Luo S., Kulak J.M., Cartier G.E., Jacobsen R.B., Yoshikami D., Olivera B.M., et al. Alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci 18 (1998) 8571-8579
26. McGehee D.S., and Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57 (1995) 521-546
27. Olausson P., Jentsch J.D., and Taylor J.R. Nicotine enhances responding with conditioned reinforcement. Psychopharmacology (Berl) 171 (2004) 173-178
28. Papke R.L., Duvoisin R.M., and Heinemann S.F. The amino terminal half of the nicotinic beta-subunit extracellular domain regulates the kinetics of inhibition by neuronal bungarotoxin. Proc Biol Sci 252 (1993) 141-148
29. Picciotto M.R., Caldarone B.J., King S.L., and Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22 (2000) 451-465
30. Rao T.S., Adams P.B., Correa L.D., Santori E.M., Sacaan A.I., Reid R.T., et al. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand. Brain Res 981 (2003) 85-98
31. Salas R., Pieri F., Fung B., Dani J.A., and De Biasi M. Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J Neurosci 23 (2003) 6255-6263
32. Salas R., Cook K.D., Bassetto L., and De Biasi M. The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47 (2004) 401-407
33. Schoepfer R., Conroy W.G., Whiting P., Gore M., and Lindstrom J. Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5 (1990) 35-48
34. Smith J.W., Mogg A., Tafi E., Peacey E., Pullar I.A., Szekeres P., et al. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology (Berl) 190 (2007) 157-170
35. Xu W., Sutcliffe C.B., Lorenzo I., Goldberg L., Dang H., Patrick J., et al. Gene targeting of the alpha7 and beta 2 subunits and the beta4, alpha3 and alpha5 cluster of neuronal nicotinic acetylcholine receptors. Soc Neurosci Abstr 391 (1997)
36. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., et al. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 96 (1999) 5746-5751
37. Xu W., Orr-Urtreger A., Nigro F., Gelber S., Sutcliffe C.B., Armstrong D., et al. Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci 19 (1999) 9298-9305